16-722535-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_023933.3(ANTKMT):c.686G>T(p.Gly229Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000212 in 1,604,302 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_023933.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ANTKMT | NM_023933.3 | c.686G>T | p.Gly229Val | missense_variant | 5/5 | ENST00000569529.6 | |
CCDC78 | NM_001378030.1 | downstream_gene_variant | ENST00000345165.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ANTKMT | ENST00000569529.6 | c.686G>T | p.Gly229Val | missense_variant | 5/5 | 1 | NM_023933.3 | P1 | |
CCDC78 | ENST00000345165.10 | downstream_gene_variant | 5 | NM_001378030.1 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000134 AC: 2AN: 149572Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000410 AC: 1AN: 243854Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 133550
GnomAD4 exome AF: 0.0000220 AC: 32AN: 1454730Hom.: 0 Cov.: 47 AF XY: 0.0000221 AC XY: 16AN XY: 723368
GnomAD4 genome AF: 0.0000134 AC: 2AN: 149572Hom.: 0 Cov.: 33 AF XY: 0.0000137 AC XY: 1AN XY: 72820
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 15, 2023 | The c.686G>T (p.G229V) alteration is located in exon 5 (coding exon 5) of the FAM173A gene. This alteration results from a G to T substitution at nucleotide position 686, causing the glycine (G) at amino acid position 229 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at